The Dow Jones Industrial Average drops sharply after the U.S. Federal Reserve pauses its rate decision. In reporting on Wednesday’s trading, NDTV says the index falls about 2.1%, equivalent to more than 1,100 points. The selloff accelerates after Fed Chair Kevin Warsh finishes a press briefing, with market weakness intensifying following his remarks. The reports characterize the move as part of a broader risk-off reaction on Wall Street, with “bears” controlling trading momentum after the central bank’s decision is communicated. While the coverage centers on the immediate market reaction, the underlying driver cited across the source is the combination of the Fed’s rate pause and the timing of Warsh’s briefing, which appears to coincide with the sharp deterioration in sentiment. The information available from the provided source emphasizes the magnitude of the decline and the sequence of events rather than sector-by-sector performance or specific policy details beyond the rate pause.
Dow Jones Falls Over 1,100 Points After Fed Rate Pause
The Dow Jones Industrial Average drops sharply after the U.S. Federal Reserve pauses its rate decision. In reporting on Wednesday’s trading, NDTV says the index falls about 2.1%, equivalent to more th...
- The Dow Jones Industrial Average declines about 2.1%.
- The drop amounts to more than 1,100 points.
- The Federal Reserve pauses its rate decision.
- The selloff accelerates after Fed Chair Kevin Warsh’s press briefing ends.
- NDTV attributes the worsening market move to the post-briefing reaction on Wall Street.
The Dow Jones Industrial Average slumped 2.1%, or over 1,100 points, as the selloff worsened sharply after Fed Chair Kevin Warsh's press briefing concluded.
3 hours agoThe Dow Jones Industrial Average slumped 2.1%, or over 1,100 points, as the selloff worsened sharply after Fed Chair Kevin Warsh's press briefing concluded.
3 hours ago
Fed holds interest rates steady as Iran tensions lift energy-price inflation risks
The U.S. Federal Reserve holds its benchmark interest rate steady for a fifth consecutive meeting on Wednesday, citing i...
Goldman-Backed Attovia Therapeutics Seeks up to $212.5 Million in US IPO
Attovia Therapeutics Inc., an early-stage biopharmaceutical company focused on immune-mediated diseases with significant...
Oil falls and stocks rise after US-Iran ceasefire framework hopes
Global markets react to shifting US-Iran diplomacy as traders weigh prospects for reduced conflict and the status of shi...